Case guide
The court report and company proposal are different records. Neither decides every talc claim.
Updated Oct 4, 202618 sources
See If You Qualify
Free · No obligation · About 2 minutes
Updated Oct 4, 202618 sources
This may apply to you if
These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.
Freda L. Wolfson · United States District Court for the District of New Jersey · Retired district judge serving as a limited-purpose special master
Finding: The January 2026 report recommends how to resolve challenges to expert testimony in the ovarian talc cases. It does not award personal injury payments or state a final result for every claim.
District of New Jersey: January 20, 2026 talc expert-evidence report (opens in a new tab) · Jan 20, 2026 · Checked Oct 3, 2026
NIEHS, with collaborating US cohort investigators · JAMA · 2020
Read the source: 2020 pooled genital-powder and ovarian-cancer study (opens in a new tab) · Checked Oct 3, 2026
NIEHS, with collaborating cancer and epidemiology investigators · Journal of Clinical Oncology · 2024
Read the source: 2024 Sister Study quantitative bias analysis (opens in a new tab) · Checked Oct 3, 2026
The process
You answer a few questions
About two minutes. Nothing is sent until you agree on the last step and press submit.
A lawyer looks at it
A lawyer at the firm reads your answers and checks them against the current case criteria.
The firm decides and gets in touch
If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.
The court report and company proposal are different records. Neither decides every talc claim. Check the cancer type, court papers and terms that apply to you.
The New Jersey court lists a shared group of talc cases under number 2738. Shared court work does not mean one result for all patients.
The public roster names district judge Michael A. Shipp and magistrate judge Rukhsanah L. Singh. A roster and docket number do not confirm the latest order or which path applies to a particular claim.
The court report proposed which expert views could be used in the case. It did not award money or decide the outcome of every claim.
Retired judge Freda L. Wolfson served as a special master for that limited task. A recommendation about what evidence may be heard is different from a final ruling that a product caused one person’s cancer.
The report says the court denied the bankruptcy plan and dismissed that case in March 2025. Those decisions were not injury payments.
Keep the bankruptcy proceeding separate from the ovarian cases and any actual offer. The report says the stay ended; it does not provide a personal payment grid or certify the status of every later case.
The July 27 company notice proposes terms for ovarian talc claims. It has conditions. It does not promise that you are included.
The SEC exhibit says participation must represent at least 95% of remaining claims under the proposal. That company condition is not a national filing deadline or proof that participation was completed.
The 2020 study found no clear link overall. The 2024 analysis found positive links after bias adjustments. Neither proves what caused your own cancer.
The first study could miss a small increase and did not examine specific powder types. The later analysis depends on recall and missing-data assumptions and overlaps the earlier Sister Study population. They are not two wholly separate populations.
Keep the exact diagnosis, product history and any case papers. Request missing care copies and ask a lawyer which filing rule applies.
Mark whether a document is a company proposal, court recommendation or agreement addressed to you. That distinction helps frame the questions; it does not certify an offer, current program acceptance or your last filing day.
Limited but consistent evidence in humans from epidemiological studies showing increased ovarian cancer risk with perineal talc use across multiple study designs and populations
Consistent positive association between perineal talc use and ovarian cancer risk, with hazard ratios typically ranging from 1.20 to 1.40
Women who used talcum powder for perineal hygiene had an odds ratio of 1.92 for ovarian cancer compared to non-users
The review is free and private. Asking for it doesn’t commit you to anything.
Register your interestThe Third Circuit Court of Appeals rejected LTL Management’s bankruptcy petition because the filing was not made in good faith. The court found that LTL was not in genuine financial distress — it was a shell entity created by J&J solely to absorb talc liabilities and file for bankruptcy protection. The court ruled that allowing profitable companies to create shell entities for the purpose of shielding themselves from legitimate tort claims would undermine the entire bankruptcy system. The ruling was upheld in 2025 when LTL attempted a second filing.
J&J has been hit with billions of dollars in talcum powder verdicts and settlements. MDL 2738 listed 69,340 pending actions on October 1, 2026. Past verdicts do not predict what any other claim is worth.
It is unlikely that J&J can successfully pursue the "Texas two-step" bankruptcy strategy again. The Third Circuit rejected the first attempt in 2023, and on March 31, 2025, Judge Christopher Lopez denied confirmation of Red River Talc's plan and dismissed that Chapter 11 case. The legal landscape has also shifted, with several states passing or considering legislation to restrict divisional merger bankruptcy tactics. While J&J could theoretically attempt a different restructuring approach, the judicial precedent is firmly against the strategy. On July 27, 2026, J&J announced a proposed resolution of ovarian claims that depends on participation representing at least 95% of remaining claims. No one can say whether it will take effect.
Checked against 16 primary sources by People's Justice editors · Updated
How we make moneyPeople's Justice research team · Updated Oct 4, 2026